Product
Description
Indication
Discovery
Preclinical
IND filing
| Research Center | Indication | Number of enrollment | Progression | ||
|---|---|---|---|---|---|
| Application submission | Ethical Approval | Start | |||
| First Affiliated Hospital of USTC | Advanced solid after multi-line therapy (Safety evaluation) | 50 |  |
|
|
| Peking University People's Hospital | Elderly recurrence (not post-transplant recurrence) or refractory AML | 10 | |
|
|
| First Affiliated Hospital of USTC | Ovarian cancer (ascites) | 30 | |
|
|
| First Affiliated Hospital of USTC | Solid tumor and hematologic tumor in children (under 18 years old) | 30 | |
|
|
© Copyright by CSPC All rights reserved. ICP备字：沪ICP备2022013361号-1
